Evidence mapPaperPMID 22483185Full record

ArticleJournal of acupuncture and meridian studies2012

The effect of herb-partition moxibustion on Toll-like receptor 4 in rabbit aorta during atherosclerosis.

Zeng-Hui Yue, Xin-Qun He, Xiao-Rong Chang, Jian-Ling Yuan, Bao-Sheng Yu, Mi Liu, Ling Fu, Liang Zhang, Li-Chao Shang

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Journal of acupuncture and meridian studies, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02269046 (A Multi-center, Randomized, Stratified, Active-controlled Trial to Evaluate the Effects of Acupuncture and Moxibustion for Hyperlipidemias), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02269046 naunknown statusstarted 2014, after this paper: background citation

A Multi-center, Randomized, Stratified, Active-controlled Trial to Evaluate the Effects of Acupuncture and Moxibustion for Hyperlipidemias

Ran2014Enrolled210Registered outcomes7Posted comparisons0ConditionsHyperlipidemiasArmsacupuncture and moxibustion, simvastatin, Therapeutic Lifestyle Change
Open the trial in the graph
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Moxibustion Activates Macrophage Autophagy and Protects Experimental Mice against Bacterial Infection.Evidence-based complementary and alternative medicine : eCAM · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zeng-Hui YueCollege of Acu-Moxibustion and Tuina, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Xin-Qun He
Xiao-Rong Chang
Jian-Ling Yuan
Bao-Sheng Yu
Mi Liu
Ling Fu
Liang Zhang
Li-Chao Shang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the mechanism of Toll-like receptor (TLR4) inhibition in the delay of formation of atherosclerosis by herb-partition moxibustion.

methodSeventy-five rabbits were randomly assigned to one of five groups: blank, atherosclerosis (AS) model, direct moxibustion, herb-partition moxibustion, and drug treatment. With the exception of the blank group, all rabbits were given a high-fat diet in addition to immunologic injury to create the AS model. The experiments were carried out for 16 weeks, at which time the aorta was removed from each rabbit. Immunohistochemical methods were used to detect the gray level of the aortic TLR4 to observe the immunologic competence of its antigens. Fluorescent quantitative polymerase chain reaction was used to detect the expression of TLR4 messenger RNA (mRNA) in the aorta.

resultsThe gray-scale value of TLR4 and the TLR4 mRNA expression significantly decreased (p<0.05) in the direct moxibustion, herb-partition moxibustion, and drug treatment groups. Furthermore, the effects of the herb-partition moxibustion and drug treatment were superior to those of the direct moxibustion.

conclusionHerb-partition moxibustion inhibits aortic TLR4 activity and mRNA expression, showing that herb-partition moxibustion delays the formation of atherosclerosis through the inhibition of TLR4 expression.

Indexed as

MagnoliopsidaPlant PreparationsAnimalsAnticholesteremic AgentsAntigensAortaAtherosclerosisAtorvastatinDiet, High-FatDisease Models, AnimalHeptanoic AcidsMoxibustionPolymerase Chain ReactionPyrrolesRabbitsRandom AllocationAnticholesteremic AgentsAntigensAtorvastatinHeptanoic AcidsPlant PreparationsPyrrolesRNA, MessengerToll-Like Receptor 4

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.